Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Clinical Radiology
|
February 12, 2019
Commentary on: mpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer?
M Czarniecki
Bioorganic & Medicinal Chemistry Letters
|
April 17, 1999
Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists
D Doller, S Chackalamannil, M Czarniecki, et al.
Journal of Medicinal Chemistry
|
April 30, 1993
Synthesis and phosphodiesterase activity of carboxylic acid mimetics of cyclic guanosine 3',5'-monophosphate
D Tulshian, M Czarniecki, R J Doll, et al.
Biochemical and Biophysical Research Communications
|
December 15, 1988
Demonstration of a 1-3 disulfide bond in a synthetic nonapeptide derived from the signal sequence and N-terminus of human gamma-interferon
B Pramanik, A Tsarbopoulos, J E Labdon, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 13, 2001
Potent, low molecular weight thrombin receptor antagonists
S Chackalamannil, D Doller, K Eagen, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1984
Mechanism of the pressor response to tetradecapeptide renin substrate in the rat
E J Sybertz, H S Ahn, T Baum, et al.
Acta Gastro-Enterologica Belgica
|
October 1, 2019
How to diagnose splenic abscesses?
M Nieciecki, M Kozuch, M Czarniecki, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
Small peptide inhibitors of smooth muscle myosin light chain kinase
F C Gaeta, L S Lehman de Gaeta, T P Kogan, et al.
Journal of Medicinal Chemistry
|
March 26, 1998
Synthesis of C3 heteroatom-substituted azetidinones that display potent cholesterol absorption inhibitory activity
B A McKittrick, K Ma, K Huie, et al.
Journal of Medicinal Chemistry
|
January 22, 1998
Synthesis and evaluation of polycyclic pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitors
Y Xia, S Chackalamannil, M Czarniecki, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Clinical Radiology
|
February 12, 2019
Commentary on: mpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer?
M Czarniecki
Bioorganic & Medicinal Chemistry Letters
|
April 17, 1999
Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists
D Doller, S Chackalamannil, M Czarniecki, et al.
Journal of Medicinal Chemistry
|
April 30, 1993
Synthesis and phosphodiesterase activity of carboxylic acid mimetics of cyclic guanosine 3',5'-monophosphate
D Tulshian, M Czarniecki, R J Doll, et al.
Biochemical and Biophysical Research Communications
|
December 15, 1988
Demonstration of a 1-3 disulfide bond in a synthetic nonapeptide derived from the signal sequence and N-terminus of human gamma-interferon
B Pramanik, A Tsarbopoulos, J E Labdon, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 13, 2001
Potent, low molecular weight thrombin receptor antagonists
S Chackalamannil, D Doller, K Eagen, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1984
Mechanism of the pressor response to tetradecapeptide renin substrate in the rat
E J Sybertz, H S Ahn, T Baum, et al.
Acta Gastro-Enterologica Belgica
|
October 1, 2019
How to diagnose splenic abscesses?
M Nieciecki, M Kozuch, M Czarniecki, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
Small peptide inhibitors of smooth muscle myosin light chain kinase
F C Gaeta, L S Lehman de Gaeta, T P Kogan, et al.
Journal of Medicinal Chemistry
|
March 26, 1998
Synthesis of C3 heteroatom-substituted azetidinones that display potent cholesterol absorption inhibitory activity
B A McKittrick, K Ma, K Huie, et al.
Journal of Medicinal Chemistry
|
January 22, 1998
Synthesis and evaluation of polycyclic pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitors
Y Xia, S Chackalamannil, M Czarniecki, et al.
Page
of 2